Nurse Practitioner, Adult Health · New York, NY
NPI
1972987121
Since 2015
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1275 York Ave
New York, NY, 10065
Phone (212) 639-6942
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
306 services
Medicare patients, 2024
182
Average age 75
Drug cost, 2024
$9.8M
1,208 prescriptions
Company payments, 2024
$269
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Linda Ouyang was code 99213 (office e&m - established), 269 times for 159 patients. In total Linda Ouyang billed 306 services in 6 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 269 | 159 | $46.22 | $12K |
| 38222 Other Organ Systems | Office | 19 | 18 | $56.16 | $1,067 |
By year: 2022 $28K for 510 services; 2023 $27K for 483 services; 2024 $15K for 306 services.
Medicare prescription drug claims, 2024
In 2024, the drug Linda Ouyang prescribed most often to Medicare patients was Acyclovir, with 151 prescriptions and refills. In total Linda Ouyang wrote 1,208 Medicare prescriptions that cost $9.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 151 | 294 | 54 | $2,857 |
| Calquence Acalabrutinib Maleate | 114 | 124 | 16 | $1.8M |
| Venclexta Venetoclax | 106 | 106 | 25 | $1.3M |
| Jakafi Ruxolitinib Phosphate | 98 | 98 | 16 | $1.3M |
| Imbruvica Ibrutinib | 97 | 106 | 14 | $1.6M |
| Hydroxyurea Generic | 69 | 135 | 24 | $1,731 |
| Imatinib Mesylate Generic | 37 | 39 | Under 11 | $114K |
| Allopurinol Generic | 35 | 49 | 17 | $232 |
| Valacyclovir Valacyclovir Hcl | 32 | 63 | 11 | $1,391 |
| Iclusig Ponatinib Hcl | 32 | 32 | Under 11 | $674K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 31 | 45 | Under 11 | $128 |
| Sprycel Dasatinib | 29 | 29 | Under 11 | $443K |
| Levofloxacin Generic | 28 | 32 | 16 | $623 |
| Prednisone Generic | 22 | 27 | Under 11 | $44.94 |
| Gleevec Imatinib Mesylate | 18 | 18 | Under 11 | $182K |
Brand drugs: 616 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Linda Ouyang $269 ($269 in general payments such as food, travel and fees) from 1 company. The largest payer was Blueprint Medicines Corporation with $269.
| Company | Payments | Amount |
|---|---|---|
| Blueprint Medicines Corporation SNY | 3 | $269 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.